Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02573896
Title Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors New Approaches to Neuroblastoma Therapy Consortium



Dinutuximab + Lenalidomide

Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Los Angeles California 90027-0700 United States Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 United States Details
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta Georgia 30322 United States Details
University of Chicago Comer Children's Hospital Chicago Illinois 60637 United States Details
Childrens Hospital Boston, Dana-Farber Cancer Institute. Boston Massachusetts 02115 United States Details
C.S Mott Children's Hospital Ann Arbor Michigan 48109 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229-3039 United States Details
Nationwide Children's Hospital Columbus Ohio 43205 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104-4318 United States Details
Cook Children's Healthcare System Fort Worth Texas 76104 United States Details
Seattle Children's Hospital Seattle Washington 98105 United States Details
*Shaded cells indicate that there was no data available from for the field